145 related articles for article (PubMed ID: 12584185)
1. Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice.
Salim EI; Wanibuchi H; Morimura K; Wei M; Mitsuhashi M; Yoshida K; Endo G; Fukushima S
Carcinogenesis; 2003 Feb; 24(2):335-42. PubMed ID: 12584185
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
[TBL] [Abstract][Full Text] [Related]
3. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens.
Yamamoto S; Konishi Y; Matsuda T; Murai T; Shibata MA; Matsui-Yuasa I; Otani S; Kuroda K; Endo G; Fukushima S
Cancer Res; 1995 Mar; 55(6):1271-6. PubMed ID: 7882321
[TBL] [Abstract][Full Text] [Related]
4. Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review.
Yamamoto S; Wanibuchi H; Hori T; Yano Y; Matsui-Yuasa I; Otani S; Chen H; Yoshida K; Kuroda K; Endo G; Fukushima S
Mutat Res; 1997 Jun; 386(3):353-61. PubMed ID: 9219572
[TBL] [Abstract][Full Text] [Related]
5. Effect of dietary treatment with dimethylarsinous acid (DMA(III)) on the urinary bladder epithelium of arsenic (+3 oxidation state) methyltransferase (As3mt) knockout and C57BL/6 wild type female mice.
Dodmane PR; Arnold LL; Pennington KL; Thomas DJ; Cohen SM
Toxicology; 2013 Mar; 305():130-5. PubMed ID: 23376817
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
7. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
8. Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study.
Okamura M; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Usui T; Tamaoki N; Mitsumori K
Toxicology; 2003 Mar; 185(1-2):17-22. PubMed ID: 12505441
[TBL] [Abstract][Full Text] [Related]
9. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S
Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060
[TBL] [Abstract][Full Text] [Related]
10. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid.
Kenyon EM; Hughes MF
Toxicology; 2001 Mar; 160(1-3):227-36. PubMed ID: 11246143
[TBL] [Abstract][Full Text] [Related]
11. Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
Ohgaki H; Fukuda M; Tohma Y; Huang H; Stoica G; Tatematsu M; Donehower LA
Mol Carcinog; 2000 Jun; 28(2):97-101. PubMed ID: 10900466
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
13. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
French J; Storer RD; Donehower LA
Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
[TBL] [Abstract][Full Text] [Related]
14. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):579-81. PubMed ID: 10874208
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium.
Finch GL; March TH; Hahn FF; Barr EB; Belinsky SA; Hoover MD; Lechner JF; Nikula KJ; Hobbs CH
Toxicol Pathol; 1998; 26(4):484-91. PubMed ID: 9715507
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
17. Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine.
Hirata A; Tsukamoto T; Yamamoto M; Takasu S; Sakai H; Ban H; Yanai T; Masegi T; Donehower LA; Tatematsu M
Oncol Rep; 2007 Oct; 18(4):755-61. PubMed ID: 17786332
[TBL] [Abstract][Full Text] [Related]
18. Understanding arsenic carcinogenicity by the use of animal models.
Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.
Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS
Toxicol Pathol; 2002; 30(6):696-704. PubMed ID: 12512871
[TBL] [Abstract][Full Text] [Related]
20. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress.
Mizoi M; Takabayashi F; Nakano M; An Y; Sagesaka Y; Kato K; Okada S; Yamanaka K
Toxicol Lett; 2005 Aug; 158(2):87-94. PubMed ID: 16039397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
